Keyword: Galvani Bioelectronics
SetPoint Medical rounded up $30 million, which will bankroll a phase 2 trial of its bioelelectronic therapy for rheumatoid arthritis.
EnteroMedics will modify its obesity-treating neuromodulation system for Galvani Bioelectronics to use in preclinical research.
GE Ventures has entered a strategic alliance with the Feinstein Institute, the research arm of New York’s Northwell Health, to advance new bioelectronic therapies and diagnostics for a range of diseases.
The emerging field of research called “bioelectronics” came one step closer to commercialization in August 2016, when GSK teamed up with Verily to launch Galvani Bioelectronics.